← All organizations

Rare Thyroid Therapeutics International AB

For profit

Also known as: Rare Thyroid Therapeutics International AB

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 30, 2022

Timeline

2010s

Jan 1, 2017
Rare Thyroid Therapeutics International AB— Founded

Drugs by trial phase (1 distinct, 2 trials)

Phase 3 (1 own, 0 via acquisition)

Tiratricol

Recent trials (2)

NCT05911399Lead sponsorN/A—
NCT05579327Lead sponsorPhase 3Nov 30, 2022

Details

Founded: Stockholm, SE Jan 1, 2017
Last known activity: Nov 30, 2022